Xiaohui Chen Nielsen

Xiaohui Chen Nielsen

Auto-generated profile, based on publicly available information

Xiaohui Chen Nielsen

Department of Clinical Microbiology, Zealand University Hospital

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2014 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
MJM. B. F. Jensen
M. B. F. Jensen
KOK. E. P. Olsen
K. E. P. Olsen
XNX. C. Nielsen
X. C. Nielsen
AHA. M. Hoegh
A. M. Hoegh
RDRam Benny Dessau
Ram Benny Dessau
JEJørgen Engberg
Jørgen Engberg
The diagnosis of Clostridium difficile infection (CDI) requires the detection of toxigenic C. difficile or its toxins and a clinical assessment. We evaluated the performance of four nucleic acid amplification tests (NAATs) detecting toxigenic C. difficile directly from faeces compared to routine toxigenic culture. In total, 300 faecal samples from Danish hospitalised patients with diarrhoea were included consecutively. Culture was performed in duplicate (routine and ‘expanded toxigenic culture’: prolonged and/or re-culture) and genotypic toxin profiling by polymerase chain reaction (PCR), PCR ribotyping and toxinotyping (TT) were performed on culture-positive samples. In parallel, the samples were analysed by four NAATs; two targeting tcdA or tcdB (illumigene® C. difficile and PCRFast® C. difficile A/B) and two multi-target real-time (RT) PCR assays also targeting cdt and tcdC alleles characteristic of epidemic and potentially more virulent PCR ribotypes 027, 066 and 078 (GeneXpert® C. difficile/Epi and an ‘in-house RT PCR’ two-step algorithm). The multi-target assays were significantly more sensitive compared to routine toxigenic culture (p < 0.05) and significantly more robust to inhibition compared to PCRFast (p < 0.001). Duplicate ‘expanded toxigenic culture’ increased the culture-positive rate by 29 % compared to routine culture. The ability of the GeneXpert and in-house assays to correctly classify PCR ribotype 027 was high (>95 %), and in-house PCR displayed 100 % correct identification of PCR ribotypes 066 and 078. Furthermore, the presence of the PCR enhancer bovine serum albumin (BSA) was found to be related to high sensitivity and low inhibition rate. Rapid laboratory diagnosis of toxigenic C. difficile by RT PCR was accurate.

1 September 2017 in Journal of Clinical Virology
Verified
Journal Article
Closed access
RTRamona Trebbien
Ramona Trebbien
TFThea Koelsen Fischer
Thea Koelsen Fischer
TKTyra G Krause
Tyra G Krause
LNLene Nielsen
Lene Nielsen
XNXiaohui Chen Nielsen
Xiaohui Chen Nielsen
HEHanne-Dorthe Emborg
Hanne-Dorthe Emborg

19 July 2023 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
RJRikke Lykke Johansen
Rikke Lykke Johansen
CSChristian Højte Schouw
Christian Højte Schouw
TMTina Vasehus Madsen
Tina Vasehus Madsen
XNXiaohui Chen Nielsen
Xiaohui Chen Nielsen
JEJørgen Engberg
Jørgen Engberg
The aim of this study was to investigate the value of syndromic diagnostic testing for a better understanding of the epidemiology of gastrointestinal infections in Denmark. Here we evaluated the QIAstat-Dx® Gastrointestinal (GI) Panel 1 assay on 18,610 fecal samples requested for analysis for enteric pathogens in Region Zealand, Denmark, in 1 year (October 1, 2021, to September 30, 2022). In total, 6905 (37%) samples were detected positive for one or more diarrhoeal bacteria, viruses, and protozoa. The most common bacterial, viral, and parasitic pathogens detected with the QIAstat-Dx® Gastrointestinal Panel 1 were EPEC (in patients ≥ 2 years of age) (n = 1420 (20.6%)), rotavirus (n = 948 (13.7%)), and Cryptosporidium spp. (n = 196 (2.84%)). We identified a large diversity in infections likely reflecting substantial differences in the epidemiology including origin of infections, mode of transmission, seasonality, age-dependent susceptibility to disease, severity, and travel history. All pathogens were detected as both single and coinfections. Viral infections peaked in March with a positive rate of 31.6%, and bacterial infections peaked in August with a positive rate of 35.3%. ETEC, Shigella/EIEC, EAEC, and P. shigelloides were most related to travel activity, and coinfections were frequent. The distribution of Ct values varied significantly between the pathogens, with the lowest Ct values (median 17–18) observed in astrovirus, adenovirus, and rotavirus. Our results highlight the value of providing extensive diagnostic testing on fecal samples for sufficient detection of relevant diarrhoeal pathogens for optimal clinical care.

11 July 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
CEChristina Schjellerup Eickhardt-Dalbøge
Christina Schjellerup Eickhardt-Dalbøge
AIAnna Cäcilia Ingham
Anna Cäcilia Ingham
LALee O'Brien Andersen
Lee O'Brien Andersen
HNHenrik V. Nielsen
Henrik V. Nielsen
KFKurt Fuursted
Kurt Fuursted
JCJens Jørgen Elmer Christensen
Jens Jørgen Elmer Christensen
Chronic inflammation is believed to play an important role in the development and disease progression of polycythemia vera (PV). Because an association between gut microbiota, hematopoiesis, and inflammation is well established, we hypothesized that patients with PV have a gut microbiota distinct from healthy control participants (HCs). Recombinant interferon alfa 2 (IFN-α2)-treatment of patients with PV is reportedly disease modifying in terms of normalization of elevated blood cell counts in concert with a reduction in the JAK2V617F allelic burden. Therefore, we hypothesized that patients treated with IFN-α2 might have a composition of the gut microbiota toward normalization. Herein, via amplicon-based next-generation sequencing of the V3 to V4 regions of the 16S ribosomal RNA gene, we report on an abnormal gut microbiota in 102 patients with PV compared with 42 HCs. Patients with PV had a lower alpha diversity and a lower relative abundance of several taxa belonging to Firmicutes (45%) compared with HCs (59%, P <.001). Furthermore, we report the composition of the gut microbiota to differ between the treatment groups (IFN-α2, hydroxyurea, no treatment, and combination therapy with IFN-α2 and ruxolitinib) and the HCs. These observations are highly interesting considering the potential pathogenetic importance of an altered gut microbiota for development of other diseases, including chronic inflammatory diseases. Our observations call for further gut microbiota studies to decipher potential causal associations between treatment and the gut microbiota in PV and related neoplasms.

16 January 2024 in European Journal of Haematology
Verified
Journal Article
Open access
CEChristina Schjellerup Eickhardt‐Dalbøge
Christina Schjellerup Eickhardt‐Dalbøge
HNHenrik V. Nielsen
Henrik V. Nielsen
KFKurt Fuursted
Kurt Fuursted
CSChristen Rune Stensvold
Christen Rune Stensvold
LALee O' Brien Andersen
Lee O' Brien Andersen
AIAnna Cäcilia Ingham
Anna Cäcilia Ingham
Background: Essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (MF) are myeloproliferative neoplasms (MPN). Inflammation is involved in the initiation, progression, and symptomology of the diseases. The gut microbiota impacts the immune system, infection control, and steady‐state hematopoiesis. Methods: We analyzed the gut microbiota of 227 MPN patients and healthy controls (HCs) using next‐generation sequencing. We expanded our previous results in PV and ET patients with additional PV, pre‐MF, and MF patients which allowed us to compare MPN patients collectively, MPN sub‐diagnoses, and MPN mutations (separately and combined) vs. HCs ( N = 42) and compare within MPN sub‐diagnoses and MPN mutation. Results: MPN patients had a higher observed richness (median, 245 [range, 49–659]) compared with HCs (191.5 [range, 111–300; p = .003]) and a lower relative abundance of taxa within the Firmicutes phylum; for example, Faecalibacterium (6% vs. 14%, p < .001). The microbiota of CALR ‐positive patients ( N = 30) resembled that of HCs more than that of patients with JAK2V617F ( N = 177). In JAK2V617F ‐positive patients, only minor differences in the gut microbiota were observed between MPN sub‐diagnoses, illustrating the importance of this mutation. Conclusion: The gut microbiota in MPN patients differs from HCs and is driven by JAK2V617F , whereas the gut microbiota in CALR patients resembles HCs more.

9 September 2025 in APMIS
Verified
Journal Article
Open access
HAHuma Aftab
Huma Aftab
CSChristian H. Schouw
Christian H. Schouw
RDRimtas Dargis
Rimtas Dargis
LVLaus K. Vejrum
Laus K. Vejrum
RJRikke L. Johansen
Rikke L. Johansen
XNXiaohui C. Nielsen
Xiaohui C. Nielsen
Sequencing of the 16S ribosomal RNA (rRNA) gene is an important tool in addition to conventional methods for the identification of bacterial pathogens in human infections. In polymicrobial samples, Sanger sequencing can produce uninterpretable chromatograms. This limitation can be overcome by Next Generation Sequencing (NGS) of the 16S rRNA gene. We investigated the applicability of Oxford Nanopore Technologies (ONT) sequencing of the partial 16S rRNA gene as a diagnostic routine method for pathogen detection in clinical samples. From June 2021 to August 2022, 101 clinical samples positive in PCR for partial 16S rRNA gene analysis were subjected to both Sanger and ONT sequencing. Sanger sequences were edited and compared with deposited sequences in the NCBI database using BLAST, while ONT data were processed using EPI2ME Fastq 16S. The positivity rate (clinically relevant pathogen) was higher for ONT vs. Sanger sequencing: 72% and 59%, respectively. Concordance between Sanger and ONT sequencing was 80%. Furthermore, ONT detected more samples with polymicrobial presence compared to Sanger (13 vs. 5) sequencing. Interestingly, in one joint fluid sample, Borrelia bissettiiae was identified by ONT but not by Sanger. The results show that the detection of both monobacterial and multiple bacterial species is improved using ONT.